Chemical Communications,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 1, 2025
Extracellular
vesicles
have
been
deemed
as
potential
drug
carriers
for
treatment
of
various
diseases.
Recent
advances
summarized,
including
the
sources,
delivery
function,
extraction
and
cargo-loading
technology
extracellular
vesicles.
Genes,
Год журнала:
2025,
Номер
16(3), С. 330 - 330
Опубликована: Март 12, 2025
Extracellular
vesicles
(EVs)
are
nanovesicles
that
facilitate
intercellular
communication
by
carrying
essential
biomolecules
under
physiological
and
pathological
conditions
including
microRNAs
(miRNAs).
They
found
in
various
body
fluids,
such
as
blood,
urine,
saliva,
their
levels
fluctuate
with
disease
progression,
making
them
valuable
diagnostic
tools.
However,
isolating
EVs
is
challenging
due
to
small
size
biological
complexity.
Here,
we
summarize
the
principles
behind
most
common
EV
isolation
methods
ultracentrifugation,
precipitation,
immunoaffinity,
sorting,
ultrafiltration,
exclusion
chromatography,
microfluidics
while
highlighting
protocol
strengths
weaknesses.
We
also
review
main
strategies
identify
quantify
circulating
miRNAs
a
particular
focus
on
EV-encapsulated
miRNAs.
Since
these
hold
special
clinical
interest
derived
from
superior
stability
therapeutic
potential,
information
provided
here
should
provide
guidance
for
future
research
initiatives
promising
field
of
treatment
based
Small
extracellular
vesicles
(sEVs)
are
with
diameters
ranging
from
30
to
150
nm,
harboring
proteins
and
nucleic
acids
that
reflect
their
source
cells
act
as
vital
mediators
of
intercellular
communication.
The
comprehensive
analysis
sEVs
is
hindered
by
the
complex
composition
biofluids
contain
various
vesicles.
Conventional
separation
methods,
such
ultracentrifugation
immunoaffinity
capture,
face
routine
challenges
in
operation
complexity,
cost,
compromised
recovery
rates.
Microfluidic
technologies,
particularly
viscoelastic
microfluidics,
offer
a
promising
alternative
for
sEV
due
its
field-free
nature,
fast
simple
procedure,
minimal
sample
consumption.
In
this
context,
we
here
introduce
an
innovative
approach
designed
exploit
viscosity
gradient-induced
force
size-dependent
characteristics,
thereby
enabling
efficient
nano-sized
particles
larger
impurities.
We
first
seek
illustrate
underlying
mechanism
force,
followed
experimental
validation
fluorescent
nanoparticles
demonstrating
results
consistent
qualitative
analysis.
believe
work
report
phenomenon
microfluidic
context.
presented
achieves
∼80%
both
target
purity
rate.
further
demonstrate
effective
using
our
device
showcase
efficacy
real
biological
highlighting
potential
versatile,
label-free
platform
fundamental
research
clinical
applications.
Frontiers in Bioengineering and Biotechnology,
Год журнала:
2024,
Номер
12
Опубликована: Сен. 27, 2024
Extracellular
vesicles
(EVs)
play
an
important
role
in
normal
life
activities
and
disease
treatment.
In
recent
years,
there
have
been
abundant
relevant
studies
focusing
on
EVs
for
cancer
therapy
showing
good
performance
tumor
inhibition.
To
enhance
the
effectiveness
of
EVs,
EV
analogs
developed.
This
review
summarizes
classification,
origin,
production,
purification,
modification,
drug
loading
treatment
applications
their
analogs.
Also,
characteristics
technologies
involved
are
analyzed,
which
provides
basis
development
application
biogenic
vesicle-based
delivery
platform
therapy.
Meanwhile,
challenges
translating
these
into
clinic,
such
as
limited
sources,
lack
production
standards,
insufficient
targeting
discussed.
With
ongoing
exploration
clinical
studies,
EV-based
drugs
will
make
great
contributions
to
Angewandte Chemie International Edition,
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 8, 2024
Abstract
Enzymes
encapsulated
in
extracellular
vesicles
(EVs)
hold
promise
as
biomarkers
for
early
cancer
diagnosis.
However,
precise
measurement
of
their
catalytic
activities
within
EVs
remains
a
notable
challenge.
Here,
we
report
an
enzymatically
triggered
spherical
DNA
nanomotor
(EDM)
that
enables
one‐pot,
cascaded,
and
highly
sensitive
analysis
the
activity
EV‐associated
or
free
apurinic/apyrimidinic
endonuclease
1
(APE1,
key
enzyme
base
excision
repair)
across
various
biological
samples.
The
EDM
capitalizes
on
APE1‐triggered
activation
DNAzyme
(Dz)
its
autonomous
cleavage
substrates
to
achieve
nonlinear
signal
amplification.
Using
EDM,
demonstrate
strong
correlation
between
APE1
parental
cells.
Additionally,
EV
mirrors
fluctuation
cellular
response
chemotherapy‐induced
damage.
In
pilot
clinical
study
(
n
=63),
EDM‐based
assay
reveals
more
than
80
%
active
serum
samples
is
EV‐encapsulated.
Notably,
can
differentiate
prostate
(PCa)
patients
from
healthy
donors
(HDs)
with
overall
accuracy
92
%,
outperforming
sera.
We
anticipate
will
become
versatile
tool
quantifying
enzymes.
Chemical Communications,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 1, 2025
Extracellular
vesicles
have
been
deemed
as
potential
drug
carriers
for
treatment
of
various
diseases.
Recent
advances
summarized,
including
the
sources,
delivery
function,
extraction
and
cargo-loading
technology
extracellular
vesicles.